AVZIVI
Live / Registered — Registered (as of 24 Jan 2023)
What this means for you
Registered since 24 Jan 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79345700
- Registration number
- 6959624
- Mark type
- Stylized text
- Filed
- 13 Apr 2022
- Published for opposition
- 08 Nov 2022
- Registered
- 24 Jan 2023
Goods and services
- Class 005 — Pharmaceuticals: Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma
Owner
- Sandoz AG, CH
- Novartis AG, CH
- Novartis AG, CH
- Novartis AG, CH
Prosecution history
- 19 Jan 2024 — CHANGE OF OWNER RECEIVED FROM IB
- 04 Apr 2023 — NOTIFICATION PROCESSED BY IB
- 16 Mar 2023 — FINAL DISPOSITION NOTICE SENT TO IB
- 16 Mar 2023 — FINAL DISPOSITION PROCESSED
- 23 Feb 2023 — GRANT OF PROTECTION CREATED, TO BE SENT TO IB
- 24 Jan 2023 — REGISTERED-PRINCIPAL REGISTER
- 08 Nov 2022 — PUBLISHED FOR OPPOSITION
- 19 Oct 2022 — NOTICE OF PUBLICATION
- 03 Oct 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 03 Oct 2022 — ASSIGNED TO EXAMINER
- 30 Jul 2022 — APPLICATION FILING RECEIPT MAILED
- 26 Jul 2022 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 25 Jul 2022 — LIMITATION FROM ORIGINAL APPLICATION ENTERED
- 21 Jul 2022 — SN ASSIGNED FOR SECT 66A APPL FROM IB